Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
Ugeskrift for Laeger|October 9, 2014
[CDKN2A-mutation in a family with hereditary malignant melanoma]Malene Djursby, Karin Wadt, Henrik Lorentzen, et al.
Breast Cancer Research : BCR|July 31, 2012
The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transitionErik Fredlund, Johan Staaf, Juha K Rantala, et al.
DNA and Cell Biology|August 11, 2007
The Wilms' tumor gene 1 (WT1) induces expression of the N-myc downstream regulated gene 2 (NDRG2)Emelie Svensson, Karina Vidovic, Tor Olofsson, et al.
Oncology Reports|September 3, 2010
Genetic profiles distinguish different types of hereditary ovarian cancerKatarina Domanska, Susanne Malander, Johan Staaf, et al.
Genome Biology|August 21, 2002
BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray dataLao H Saal, Carl Troein, Johan Vallon-Christersson, et al.
Melanoma Research|June 8, 2010
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotypeKari Nielsen, Katja Harbst, Anna Måsbäck, et al.
Acta Oncologica (Stockholm, Sweden)|April 29, 2006
p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neckEva Henriksson, Bo Baldetorp, Ake Borg, et al.
Gynecologic Oncology|December 20, 2005
The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancerSusanne Malander, Eva Rambech, Ulf Kristoffersson, et al.
Sarcoma|February 7, 2009
Genetic profiling differentiates second primary tumors from metastases in adult metachronous soft tissue sarcomaJosefin Fernebro, Ana Carneiro, Anders Rydholm, et al.
Plos One|August 17, 2013
Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type xMev Dominguez-Valentin, Christina Therkildsen, Srinivas Veerla, et al.
Pageof 15